1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > Generic Drug Analysis & Statistics in Europe Countries, June 2015

Generic Drug Analysis & Statistics in Europe Countries, June 2015

1-19 of 19 reports

Purchase Reports From Reputable Market Research Publishers

Portugal Pharmaceuticals and Healthcare Report Q1 2015

Portugal Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Portuguese government measures to reduce public spending on medicines will continue to weigh on the pharmaceutical sector over a multi-quarter horizon, ...

  • Industries : Pharmaceutical, Drug and Medication, Healthcare
  • Countries : Portugal
Portugal Pharmaceuticals and Healthcare Report Q4 2014

Portugal Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Despite Portugal's stronger-than-expected economic expansion in previous quarters, government austerity measures will continue to weigh on drug spending over the medium term. This is reflected ...

  • Industries : Pharmaceutical, Drug and Medication, Healthcare
  • Countries : Portugal
Portugal Pharmaceuticals and Healthcare Report Q3 2014

Portugal Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and pharmaceutical forecasts slightly upwards. As forecast previously, ...

  • Industries : Pharmaceutical, Drug and Medication, Healthcare
  • Countries : Portugal
Portugal Pharmaceuticals and Healthcare Report Q2 2014

Portugal Pharmaceuticals and Healthcare Report Q2 2014

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While Portugal's economy is expected to register growth in FY14, we expect that IMF-imposed austerity measures and household deleveraging will continue to be ...

  • Industries : Pharmaceutical, Drug and Medication
  • Countries : Portugal
Generics in the United Kingdom, MarketLine

Generics in the United Kingdom, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Generics in Belgium, MarketLine

Generics in Belgium, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Belgium
Generics in France, MarketLine

Generics in France, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : France
Generics in Germany, MarketLine

Generics in Germany, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile ...

  • Industries : Generic Drug
  • Countries : Germany
Generics in Italy, MarketLine

Generics in Italy, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : Italy
Generics in Spain, MarketLine

Generics in Spain, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also ...

  • Industries : Generic Drug
  • Countries : Spain
Generics in the Netherlands, MarketLine

Generics in the Netherlands, MarketLine

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The ...

  • Industries : Generic Drug
  • Countries : Netherlands
Biogaran, Laboratoires in Consumer Health (France)

Biogaran, Laboratoires in Consumer Health (France)

  • $ 153
  • Company report
  • June 2013
  • by Euromonitor International

Laboratoires Biogaran is expected to maintain its focus on its core business activities: the development, manufacturing, marketing and distribution of generics. With the reinforcement of “Third party ...

  • Industries : Generic Drug, Healthcare
  • Countries : France
Orifarm A/S in Consumer Health (Denmark)

Orifarm A/S in Consumer Health (Denmark)

  • $ 153
  • Company report
  • May 2013
  • by Euromonitor International

Orifarm A/S is a fast growing supplier of parallel imported and generic pharmaceuticals. Orifarm’s strategic focus is to strengthen its position as the leading supplier of parallel imports and generic ...

  • Industries : Pharmaceutical, Healthcare, Generic Drug
  • Countries : Denmark
Gauging the Biosimilar Effect: will  the market boom or bust?

Gauging the Biosimilar Effect: will the market boom or bust?

  • $ 895
  • Industry report
  • January 2012
  • by Firstword Pharma

It was supposed to be the “epoch of biosimilars”, or drugs that copied existing biologics but had the potential to be more cost-effective. Yet five years later, biosimilars have failed to reach ...

  • Industries : Generic Drug
  • Countries : Germany
UK Generics Market Analysis

UK Generics Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The UK is one of the largest economies in the world. The per capita income and spending has been also increasing for the last few years. Besides, due to the increasing consumer spending on the branded ...

  • Industries : Generic Drug
  • Countries : United Kingdom
United Kingdom: Pharmaceuticals Industry Guide

United Kingdom: Pharmaceuticals Industry Guide

  • $ 795
  • Industry report
  • March 2011
  • by MarketLine

Datamonitor's United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the United Kingdom Pharmaceuticals industry. It includes detailed data on ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom
Sanofi-Aventis Generics Company Intelligence Report

Sanofi-Aventis Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Brazil, Czech Republic
Stada Arzneimittel Generics Company Intelligence Report

Stada Arzneimittel Generics Company Intelligence Report

  • $ 329
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Countries : Germany
Zentiva Generics Company Intelligence Report

Zentiva Generics Company Intelligence Report

  • $ 331
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Zentiva was created through the merger of the Czech company, Léciva, and the Slovak firm Slovakofarma, which was completed in August 2003. The two former companies began selling products under the Zentiva ...

  • Industries : Generic Drug
  • Countries : Turkey, Czech Republic, Slovakia (Slovak Republic)



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.